Embolic Protection Device Market By Type, Material, Application, Indication And End User - Global Industry Analysis And Forecast To 2023
Published On : June 2022 Pages : 180 Category: Medical Devices Report Code : HC06862
Industry Outlook & Trend Analysis.
The Embolic Protection Device market was worth USD 0.28 billion in 2017 and is expected to reach approximately USD 0.56 billion by 2023 at a CAGR of 8.11%. Embolic Protection Devices are used to clear the debris released into blood stream and blocking the smaller vessels. These devices are used to avoid complications that arise due to the blockage during the cardiac procedures. Increasing incidents of cardiovascular and neurovascular diseases, demand for less complicated cardiac procedures and investments being made to develop a technologically advanced Embolic Protection Devices are factors that are predicted to drive the market.
Type Outlook & Trend Analysis
Based on type, the market is divided into Distal Filter, Distal Occlusion and Proximal Occlusion. The distal filter allows the blood to circulate through it and then collects the embolic debris. The Distal Filter due to its ease of use, crossing profile and augmented visibility has gained popularity. It contributes the largest share in market and is expected to grow at highest rate.
Material Outlook & Trend Analysis
On the basis of materials, the Embolic Protection market is divided into Nitinol and Polyurethane. The Nitinol segment holds the largest share in terms of volume and value in the market owing to its super elastic material and braided nitinol which provides full wall cohesion. This factor will propel the growth of nitinol section during the forecast.
Application Outlook & Trend Analysis
Based on application the market is divided into Cardiovascular, Neurovascular and Peripheral. The Neurovascular segment is predicted to grow at a substantial rate due to increase in population of patients and rising demand of Embolic Protection Devices.
Indication Outlook & Trend Analysis
The Indication based market is segmented as Percutaneous Coronary Intervention (PCI), Saphenous Vein Graft Disease (SVD), Carotid Artery Diseases (CAD) and Trans Catheter Aortic Valve Replacement (TAVR). The Percutaneous Coronary Intervention (PCI) hold the largest share in the market due to popularity of CAD and Rising Demand for less complicated cardiac procedures.
End User Outlook & Trend Analysis
The end users in the market are segmented as, Hospitals and Ambulatory Surgical Centers (ASC). Due to initiatives taken by government to provide quality cardiovascular treatment, increasing no. of hospitals, increasing incidences of chronic cardiovascular and neurovascular diseases, increasing number of angioplasty’s performed at hospitals, the hospital segment in end user of Embolic Protection Devices holds the largest share and is expected to grow during the forecast.
Regional Outlook & Trend Analysis
According to the region the market is divided into North America, Asia-Pacific, Europe and Rest of World. Due to increasing old aged population, increasing demand of minimum complicated procedures, investments made in technological advancements and presence of leading companies in the region, The North America’s Embolic Protection Device market holds the largest share in the regional market segment. The APAC region is foreseen to grow with highest CAGR during the forecast period due to increase in old aged population, improved medical facilities and increasing expenditure on healthcare.
Competitive Insights
The leading players in market are Abbott Laboratories, Medtronic, Claret Medical, Cardinal Health, Boston Scientific, Gore Medical, Allium Medical, Metactive Medical, LLC, Keystone Heart Ltd., Innovative Cardiovascular Solutions, Contego Medical and Edward Lifesciences. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Embolic Protection Device Market is segmented as follows-
By Type:
- Distal Filter
- Distal Occlusion
- Proximal Occlusion
By Material:
- Nitinol
- Polyurethane
By Application:
- Cardiovascular
- Neurovascular
- Peripheral
By Indication:
- Percutaneous Coronary Intervention (PCI)
- Saphenous Vein Graft Disease (SVD)
- Carotid Artery Diseases (CAD)
- Trans Catheter Aortic Valve Replacement (TAVR)
By End User:
- Hospitals
- Ambulatory Surgical Centers (ASC)
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Embolic Protection Devices Market, By Type, Estimates and Forecast, 2014-2023 ($Million)
o Distal Filter
o Distal Occlusion
o Proximal Occlusion
· Embolic Protection Devices Market, By Material, Estimates and Forecast, 2014-2023 ($Million)
o Nitinol
o Polyurethane
· Embolic Protection Devices Market, By Application, Estimates and Forecast, 2014-2023 ($Million)
o Cardiovascular
o Neurovascular
o Peripheral
· Embolic Protection Devices Market, By Indication, Estimates and Forecast, 2014-2023 ($Million)
o Percutaneous Coronary Intervention (PCI)
o Saphenous Vein Graft Disease (SVD)
o Carotid Artery Diseases (CAD)
o Trans Catheter Aortic Valve Replacement (TAVR)
· Embolic Protection Devices Market, By End User, Estimates and Forecast, 2014-2023 ($Million)
o Hospitals
o Ambulatory Surgical Centers (ASC)
· Embolic Protection Devices Market, By Region, Estimates and Forecast, 2014-2023 ($Million)
o North America
§ North America Embolic Protection Devices Market, By Country
o U.S. Embolic Protection Devices Market
o Canada Embolic Protection Devices Market
o Mexico Embolic Protection Devices Market
o Europe
§ Europe Embolic Protection Devices Market, By Country
o Germany Embolic Protection Devices Market
o UK Embolic Protection Devices Market
o France Embolic Protection Devices Market
o Russia Embolic Protection Devices Market
o Italy Embolic Protection Devices Market
o Rest of Europe Embolic Protection Devices Market
o Asia-Pacific
§ Asia-Pacific Embolic Protection Devices Market, By Country
o China Embolic Protection Devices Market
o Japan Embolic Protection Devices Market
o South Korea Embolic Protection Devices Market
o India Embolic Protection Devices Market
o Southeast Asia Embolic Protection Devices Market
o Rest of Asia-Pacific Embolic Protection Devices Market
o South America
§ South America Embolic Protection Devices Market
o Brazil Embolic Protection Devices Market
o Argentina Embolic Protection Devices Market
o Columbia Embolic Protection Devices Market
o South Africa Embolic Protection Devices Market
o Rest of South America Embolic Protection Devices Market
o Middle East and Africa
§ Middle East and Africa Embolic Protection Devices Market
o Saudi Arabia Embolic Protection Devices Market
o UAE Embolic Protection Devices Market
o Egypt Embolic Protection Devices Market
o Nigeria Embolic Protection Devices Market
o South Africa Embolic Protection Devices Market
o Rest of MEA Embolic Protection Devices Market
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Advancements In Technology
3.2.1.2. Increase In Number of Incidence of Cardiovascular and Neurovascular Diseases
3.2.1.3. R&D Investments for Embolic Protection Devices
3.2.1.4. Popular Demand For Minimal Invasive Procedure
3.2.2. Restraints
3.2.2.1. Failure of Product in Performing Desired Activity
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
5. Embolic Protection Devices Market, By Type
5.1. Introduction
5.2. Global Embolic Protection Devices Sales, Revenue and Market Share By Type (2017-2027)
5.2.1. Global Embolic Protection Devices Sales and Sales Share By Type (2017-2027)
5.2.2. Global Embolic Protection Devices Revenue and Revenue Share By Type (2017-2027)
5.3. Distal Filter
5.3.1. Global Distal Filter Sales and Growth Rate (2017-2027)
5.4. Distal Occlusion
5.4.1. Global Distal Occlusion Sales and Growth Rate (2017-2027)
5.5. Proximal Occlusion
5.5.1. Global Proximal Occlusion Sales and Growth Rate (2017-2027)
6. Embolic Protection Devices Market, By Material
6.1. Introduction
6.2. Global Embolic Protection Devices Sales, Revenue and Market Share By Material (2017-2027)
6.2.1. Global Embolic Protection Devices Sales and Sales Share By Material (2017-2027)
6.2.2. Global Embolic Protection Devices Revenue and Revenue Share By Material (2017-2027)
6.3. Nitinol
6.3.1. Global Nitinol Sales and Growth Rate (2017-2027)
6.4. Polyurethane
6.4.1. Global Polyurethane Sales and Growth Rate (2017-2027)
7. Embolic Protection Devices Market, By Application
7.1. Introduction
7.2. Global Embolic Protection Devices Sales, Revenue and Market Share By Application (2017-2027)
7.2.1. Global Embolic Protection Devices Sales and Sales Share By Application (2017-2027)
7.2.2. Global Embolic Protection Devices Revenue and Revenue Share By Application (2017-2027)
7.3. Cardiovascular
7.3.1. Global Cardiovascular Sales and Growth Rate (2017-2027)
7.4. Neurovascular
7.4.1. Global Neurovascular Sales and Growth Rate (2017-2027)
7.5. Peripheral
7.5.1. Global Peripheral Sales and Growth Rate (2017-2027)
8. Embolic Protection Devices Market, By Indication
8.1. Introduction
8.2. Global Embolic Protection Devices Sales, Revenue and Market Share By Application (2017-2027)
8.2.1. Global Embolic Protection Devices Sales and Sales Share By Application (2017-2027)
8.2.2. Global Embolic Protection Devices Revenue and Revenue Share By Application (2017-2027)
8.3. Percutaneous Coronary Intervention (PCI)
8.3.1. Global Percutaneous Coronary Intervention (PCI) Sales and Growth Rate (2017-2027)
8.4. Saphenous Vein Graft Disease (SVD)
8.4.1. Global Saphenous Vein Graft Disease (SVD) Sales and Growth Rate (2017-2027)
8.5. Carotid Artery Diseases (CAD)
8.5.1. Global Carotid Artery Diseases (CAD) Sales and Growth Rate (2017-2027)
8.6. Trans Catheter Aortic Valve Replacement (TAVR)
8.6.1. Global Trans Catheter Aortic Valve Replacement (TAVR) Sales and Growth Rate (2017-2027)
9. Embolic Protection Devices Market, By End User
9.1. Introduction
9.2. Global Embolic Protection Devices Sales, Revenue and Market Share by End User (2017-2027)
9.2.1. Global Embolic Protection Devices Sales and Sales Share by End User (2017-2027)
9.2.2. Global Embolic Protection Devices Revenue and Revenue Share by End User (2017-2027)
9.3. Hospitals
9.3.1. Global Hospitals Sales and Growth Rate (2017-2027)
9.4. Ambulatory Surgical Centers (ASC)
9.4.1. Global Ambulatory Surgical Centers (ASC) Sales and Growth Rate (2017-2027)
10. Embolic Protection Devices Market, By Region
10.1. Introduction
10.2. Global Embolic Protection Devices Sales, Revenue and Market Share by Regions
10.2.1. Global Embolic Protection Devices Sales by Regions (2017-2027)
10.2.2. Global Embolic Protection Devices Revenue by Regions (2017-2027)
10.3. North America Embolic Protection Devices by Countries
10.3.1. North America Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.3.2. North America Embolic Protection Devices Revenue and Growth Rate (2017-2027)
10.3.3. North America Embolic Protection Devices Sales by Countries (2017-2027)
10.3.4. North America Embolic Protection Devices Revenue (Million USD) by Countries (2017-2027)
10.3.5. U.S.
10.3.5.1. United States Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.3.5.2. United States Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.3.6. Canada
10.3.6.1. Canada Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.3.6.2. Canada Embolic Protection Devices Sales (Millions USD) and Growth Rate (2017-2027)
10.3.7. Mexico
10.3.7.1. Mexico Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.3.7.2. Mexico Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.4. Europe Embolic Protection Devices by Countries
10.4.1. Europe Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.4.2. Europe Embolic Protection Devices Revenue and Growth Rate (2017-2027)
10.4.3. Europe Embolic Protection Devices Sales by Countries (2017-2027)
10.4.4. Europe Embolic Protection Devices Revenue (Million USD) by Countries (2017-2027)
10.4.5. Germany
10.4.5.1. Germany Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.4.5.2. Germany Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.6. UK
10.4.6.1. UK Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.4.6.2. UK Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.7. France
10.4.7.1. France Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.4.7.2. France Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.8. Russia
10.4.8.1. Russia Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.4.8.2. Russia Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.9. Italy
10.4.9.1. Italy Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.4.9.2. Italy Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.4.10. Rest of Europe
10.4.10.1. Rest of Europe Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.4.10.2. Rest of Europe Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.5. Asia-Pacific
10.5.1. Asia-Pacific Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.5.2. Asia-Pacific Embolic Protection Devices Revenue and Growth Rate (2017-2027)
10.5.3. Asia-Pacific Embolic Protection Devices Sales by Countries (2017-2027)
10.5.4. Asia-Pacific Embolic Protection Devices Revenue (Million USD) by Countries (2017-2027)
10.5.5. China
10.5.5.1. China Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.5.5.2. China Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.6. Japan
10.5.6.1. Japan Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.5.6.2. Japan Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.7. Korea
10.5.7.1. Korea Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.5.7.2. Korea Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.8. India
10.5.8.1. India Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.5.8.2. India Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.9. Southeast Asia
10.5.9.1. Southeast Asia Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.5.9.2. Southeast Asia Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.5.10. Rest of Asia-Pacific
10.5.10.1. Rest of Asia-Pacific Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.5.10.2. Rest of Asia-Pacific Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.6. South America
10.6.1. South America Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.6.2. South America Embolic Protection Devices Revenue and Growth Rate (2017-2027)
10.6.3. South America Embolic Protection Devices Sales by Countries (2017-2027)
10.6.4. South America Embolic Protection Devices Revenue (Million USD) by Countries (2017-2027)
10.6.5. Brazil
10.6.5.1. Brazil Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.6.5.2. Brazil Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.6. Argentina
10.6.6.1. Argentina Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.6.6.2. Argentina Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.7. Columbia
10.6.7.1. Columbia Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.6.7.2. Columbia Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.6.8. Rest of South America
10.6.8.1. Rest of South America Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.6.8.2. Rest of South America Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.7. Middle East and Africa
10.7.1. Middle East and Africa Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.7.2. Middle East and Africa Embolic Protection Devices Revenue and Growth Rate (2017-2027)
10.7.3. Middle East and Africa Embolic Protection Devices Sales by Countries (2017-2027)
10.7.4. Middle East and Africa Embolic Protection Devices Revenue (Million USD) by Countries (2017-2027)
10.7.5. Saudi Arabia
10.7.5.1. Saudi Arabia Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.7.5.2. Saudi Arabia Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.6. United Arab Emirates
10.7.6.1. United Arab Emirates Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.7.6.2. United Arab Emirates Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.7. Egypt
10.7.7.1. Egypt Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.7.7.2. Egypt Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.8. Nigeria
10.7.8.1. Nigeria Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.7.8.2. Nigeria Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.9. South Africa
10.7.9.1. South Africa Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.7.9.2. South Africa Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
10.7.10. Rest of Middle East and Africa
10.7.10.1. Rest of Middle East and Africa Embolic Protection Devices Sales and Growth Rate (2017-2027)
10.7.10.2. Rest of Middle East and Africa Embolic Protection Devices Revenue (Millions USD) and Growth Rate (2017-2027)
11. Company Profiles
11.1. Abbott Laboratories
11.1.1. Business Overview
11.1.2. Product Portfolio
11.1.3. Strategic Developments
11.1.4. Sales, Revenue and Market Share
11.2. Medtronic
11.2.1. Business Overview
11.2.2. Product Portfolio
11.2.3. Strategic Developments
11.2.4. Sales, Revenue and Market Share
11.3. Claret Medical
11.3.1. Business Overview
11.3.2. Product Portfolio
11.3.3. Strategic Developments
11.3.4. Sales, Revenue and Market Share
11.4. Cardinal Health
11.4.1. Business Overview
11.4.2. Product Portfolio
11.4.3. Strategic Developments
11.4.4. Sales, Revenue and Market Share
11.5. Boston Scientific
11.5.1. Business Overview
11.5.2. Product Portfolio
11.5.3. Strategic Developments
11.5.4. Sales, Revenue and Market Share
11.6. Gore Medical
11.6.1. Business Overview
11.6.2. Product Portfolio
11.6.3. Strategic Developments
11.6.4. Sales, Revenue and Market Share
11.7. Allium Medical
11.7.1. Business Overview
11.7.2. Product Portfolio
11.7.3. Strategic Developments
11.7.4. Sales, Revenue and Market Share
11.8. Metactive Medical
11.8.1. Business Overview
11.8.2. Product Portfolio
11.8.3. Strategic Developments
11.8.4. Sales, Revenue and Market Share
11.9. Keystone Heart Ltd.
11.9.1. Business Overview
11.9.2. Product Portfolio
11.9.3. Strategic Developments
11.9.4. Sales, Revenue and Market Share
11.10.Innovative Cardiovascular Solutions
11.10.1. Business Overview
11.10.2. Product Portfolio
11.10.3. Strategic Developments
11.10.4. Sales, Revenue and Market Share
11.11.Contego Medical
11.11.1. Business Overview
11.11.2. Product Portfolio
11.11.3. Strategic Developments
11.11.4. Sales, Revenue and Market Share
11.12.Edward Lifesciences
11.12.1. Business Overview
11.12.2. Product Portfolio
11.12.3. Strategic Developments
11.12.4. Sales, Revenue and Market Share
12. Global Embolic Protection Devices Market Competition, by Manufacturer
12.1. Global Embolic Protection Devices Sales and Market Share by Manufacturer (2017-2017)
12.2. Global Embolic Protection Devices Revenue and Market Share by Manufacturer (2017-2017)
12.3. Global Embolic Protection Devices Price by Manufacturer (2017-2017)
12.4. Top 5 Embolic Protection Devices Manufacturer Market Share
12.5. Market Competition Trend
13. Embolic Protection Devices Market Forecast (2027-2023)
13.1. Global Embolic Protection Devices Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
13.2. Embolic Protection Devices Market Forecast by Regions (2027-2023)
13.2.1. North America Embolic Protection Devices Market Forecast (2027-2023)
13.2.1.1. United States Embolic Protection Devices Market Forecast (2027-2023)
13.2.1.2. Canada Embolic Protection Devices Market Forecast (2027-2023)
13.2.1.3. Mexico Embolic Protection Devices Market Forecast (2027-2023)
13.2.2. Europe Embolic Protection Devices Market Forecast (2027-2023)
13.2.2.1. Germany Embolic Protection Devices Market Forecast (2027-2023)
13.2.2.2. United Kingdom Embolic Protection Devices Market Forecast (2027-2023)
13.2.2.3. France Embolic Protection Devices Market Forecast (2027-2023)
13.2.2.4. Russia Embolic Protection Devices Market Forecast (2027-2023)
13.2.2.5. Italy Embolic Protection Devices Market Forecast (2027-2023)
13.2.2.6. Rest of the Europe Embolic Protection Devices Market Forecast (2027-2023)
13.2.3. Asia-Pacific Embolic Protection Devices Market Forecast (2027-2023)
13.2.3.1. China Embolic Protection Devices Market Forecast (2027-2023)
13.2.3.2. Japan Embolic Protection Devices Market Forecast (2027-2023)
13.2.3.3. Korea Embolic Protection Devices Market Forecast (2027-2023)
13.2.3.4. India Embolic Protection Devices Market Forecast (2027-2023)
13.2.3.5. Southeast Asia Embolic Protection Devices Market Forecast (2027-2023)
13.2.3.6. Rest of Asia-Pacific Embolic Protection Devices Market Forecast (2027-2023)
13.2.4. South America Embolic Protection Devices Market Forecast (2027-2023)
13.2.4.1. Brazil Embolic Protection Devices Market Forecast (2027-2023)
13.2.4.2. Argentina Embolic Protection Devices Market Forecast (2027-2023)
13.2.4.3. Columbia Embolic Protection Devices Market Forecast (2027-2023)
13.2.4.4. Rest of South America Embolic Protection Devices Market Forecast (2027-2023)
13.2.5. Middle East and Africa Embolic Protection Devices Market Forecast (2027-2023)
13.2.5.1. Saudi Arabia Embolic Protection Devices Market Forecast (2027-2023)
13.2.5.2. UAE Embolic Protection Devices Market Forecast (2027-2023)
13.2.5.3. Egypt Embolic Protection Devices Market Forecast (2027-2023)
13.2.5.4. Nigeria Embolic Protection Devices Market Forecast (2027-2023)
13.2.5.5. South Africa Embolic Protection Devices Market Forecast (2027-2023)
13.2.5.6. Rest of MEA Embolic Protection Devices Market Forecast (2027-2023)
13.3. Embolic Protection Devices Market Forecast By Type (2027-2023)
13.3.1. Global Embolic Protection Devices Sales Forecast By Type(2027-2023)
13.3.2. Global Embolic Protection Devices Sales Market Share Forecast By Type (2027-2023)
13.4. Embolic Protection Devices Market Forecast By Material (2027-2023)
13.4.1. Global Embolic Protection Devices Sales Forecast By Material (2027-2023)
13.4.2. Global Embolic Protection Devices Sales Market Share Forecast By Material (2027-2023)
13.5. Embolic Protection Devices Market Forecast by End User (2027-2023)
13.5.1. Global Embolic Protection Devices Sales Forecast by End User (2027-2023)
13.5.2. Global Embolic Protection Devices Sales Market Share Forecast by End User (2027-2023)
List of Tables
*You can glance through the list of Tables and Figures when you view the sample copy of Embolic Protection Devices Market.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|